Related Experiment Video
Updated: Oct 12, 2025

Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
O-GlcNAcylation regulation of cellular signaling in cancer
Lorela Ciraku1, Emily M Esquea1, Mauricio J Reginato2
1Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA.
Abstract:
O-GlcNAcylation is a post-translational modification occurring on serine/threonine residues of nuclear and cytoplasmic proteins, mediated by the enzymes OGT and OGA which catalyze the addition or removal of the UDP-GlcNAc moieties, respectively. Structural changes brought by this modification lead to alternations of protein stability, protein-protein interactions, and phosphorylation. Importantly, O-GlcNAcylation is a nutrient sensor by coupling nutrient sensing with cellular signaling. Elevated levels of OGT and O-GlcNAc have been reported in a variety of cancers and has been linked to regulation of multiple cancer signaling pathways. In this review, we discuss the most recent findings on the role of O-GlcNAcylation as a metabolic sensor in signaling pathways and immune response in cancer.
Insights
O-GlcNAcylation, a nutrient-sensing modification, impacts protein function and cancer signaling. Elevated O-GlcNAcylation regulates cancer pathways and immune responses, highlighting its critical role in oncology.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- O-GlcNAcylation is a dynamic post-translational modification on serine/threonine residues.
- It is regulated by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA).
- O-GlcNAcylation influences protein stability, interactions, and phosphorylation, acting as a nutrient sensor.
Purpose of the Study:
- To review recent findings on O-GlcNAcylation in cancer.
- To explore its role as a metabolic sensor in cancer signaling pathways.
- To discuss its involvement in the immune response within the tumor microenvironment.
Main Methods:
- Literature review of recent studies on O-GlcNAcylation and cancer.
- Analysis of the regulatory mechanisms of OGT and OGA in cancer.
- Examination of O-GlcNAcylation's impact on key cancer signaling pathways.
Main Results:
- Elevated OGT and O-GlcNAc levels are observed in various cancers.
- O-GlcNAcylation modulates critical cancer-related signaling pathways.
- This modification influences the anti-tumor immune response.
Conclusions:
- O-GlcNAcylation is a key player in cancer development and progression.
- Targeting O-GlcNAcylation pathways presents potential therapeutic strategies for cancer.
- Further research is needed to fully elucidate its complex roles in cancer biology.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a...
GPCRs Regulate Adenylyl Cylase Activity

